Evidence map›Paper›PMID 35113770›Full record

ArticleHuman vaccines & immunotherapeutics2022

Recommendations for the ethical conduct of vaccination awareness campaigns by biopharmaceutical companies.

Claar van der Zee, Veronique Delpire, Volker Vetter, Tatjana Poplazarova

Abstract read
In one paragraph

Article in Human vaccines & immunotherapeutics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Claar van der ZeeOffice of the Chief Medical Officer, GSK, Wavre, Belgium.ORCID 0000-0002-4132-2589
Veronique DelpireWords & Science, Brussels, Belgium.ORCID 0000-0003-4819-3924
Volker VetterGlobal Medical Affairs, GSK, Wavre, Belgium.ORCID 0000-0002-8414-1657
Tatjana PoplazarovaOffice of the Chief Medical Officer, GSK, Wavre, Belgium.ORCID 0000-0002-1121-0236

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Health awareness campaigns educate and inform the public about particular health conditions with the aim of either changing behavior or enhancing uptake of appropriate healthcare, such as vaccination or screening. The campaigns may be run by governments and public health bodies but are also deployed by biopharmaceutical companies. Industry-sponsored disease awareness (DA) campaigns intend to provide information about diseases and their prevention or treatment, without mentioning specific products. In most countries, DA campaigns fall outside of the laws and regulations that apply to promotion of medicines. Currently, guidance for industry is limited and only exists at national level. This article provides an overview of existing guidance on DA campaigns, discusses benefits and risks, and proposes recommendations for industry-sponsored vaccination awareness campaigns.

Indexed as

Biological ProductsHealth PromotionImmunization ProgramsPublic HealthVaccinationBiological ProductsDisease awareness campaignsethicspharmaceutical industryvaccinationvaccination awareness campaignsvaccine-preventable diseases

Identifiers

PMID35113770
PMCPMC8986232

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.